Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C404192 |
2-pyridylcarboxaldehyde isonicotinoylhydrazone |
2-pyridylcarboxaldehyde isonicotinoylhydrazone inhibits the reaction [Doxorubicin promotes the reaction [Iron binds to [FTL protein binds to FTMT protein]]] | affects binding|decreases reaction|increases reaction | 12644586
|
C404192 |
2-pyridylcarboxaldehyde isonicotinoylhydrazone |
2-pyridylcarboxaldehyde isonicotinoylhydrazone inhibits the reaction [Iron binds to [FTL protein binds to FTMT protein]] | affects binding|decreases reaction | 12644586
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of FTL mRNA | affects expression | 16483693
|
C006632 |
arsenic trioxide |
arsenic trioxide results in increased expression of FTL mRNA | increases expression | 20458559
|
C072553 |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [diallyl trisulfide results in increased degradation of and results in decreased expression of FTL protein] | decreases expression|decreases reaction|increases degradation | 16707465
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of FTL mRNA | increases expression | 12414654 15963989
|
D002104 |
Cadmium |
Cadmium binds to FTL protein | affects binding | 16790936
|
C055494 |
caffeic acid phenethyl ester |
[Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of FTL mRNA | affects cotreatment|decreases expression | 20360939
|
D002330 |
Carmustine |
Carmustine results in decreased expression of FTL mRNA | decreases expression | 15980968
|
D002784 |
Cholesterol |
Cholesterol results in decreased expression of FTL protein | decreases expression | 17029598
|
D003300 |
Copper |
Copper affects the expression of FTL protein | affects expression | 17192175
|
D003300 |
Copper |
Copper promotes the reaction [[Iron co-treated with Diethylnitrosamine] results in increased expression of FTL mRNA] | affects cotreatment|increases expression|increases reaction | 20302851
|
D015084 |
2,4-Dichlorophenoxyacetic Acid |
2,4-Dichlorophenoxyacetic Acid results in increased expression of FTL mRNA | increases expression | 15878651
|
D003676 |
Deferoxamine |
Deferoxamine inhibits the reaction [Doxorubicin promotes the reaction [Iron binds to [FTL protein binds to FTMT protein]]] | affects binding|decreases reaction|increases reaction | 12644586
|
D003676 |
Deferoxamine |
Deferoxamine inhibits the reaction [Iron binds to [FTL protein binds to FTMT protein]] | affects binding|decreases reaction | 12644586
|
C042577 |
diallyl trisulfide |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [diallyl trisulfide results in increased degradation of and results in decreased expression of FTL protein] | decreases expression|decreases reaction|increases degradation | 16707465
|
C042577 |
diallyl trisulfide |
diallyl trisulfide results in increased degradation of and results in decreased expression of FTL protein | decreases expression|increases degradation | 16707465
|
C042577 |
diallyl trisulfide |
MAP2K4 protein affects the reaction [diallyl trisulfide results in increased degradation of FTL protein] | affects reaction|increases degradation | 16707465
|
C042577 |
diallyl trisulfide |
MAP2K7 protein affects the reaction [diallyl trisulfide results in increased degradation of FTL protein] | affects reaction|increases degradation | 16707465
|
D004052 |
Diethylnitrosamine |
Copper promotes the reaction [[Iron co-treated with Diethylnitrosamine] results in increased expression of FTL mRNA] | affects cotreatment|increases expression|increases reaction | 20302851
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of FTL mRNA | affects cotreatment|decreases expression | 20360939
|
D004052 |
Diethylnitrosamine |
[Iron co-treated with Diethylnitrosamine] results in increased expression of FTL mRNA | affects cotreatment|increases expression | 20302851
|
D004317 |
Doxorubicin |
2-pyridylcarboxaldehyde isonicotinoylhydrazone inhibits the reaction [Doxorubicin promotes the reaction [Iron binds to [FTL protein binds to FTMT protein]]] | affects binding|decreases reaction|increases reaction | 12644586
|
D004317 |
Doxorubicin |
Deferoxamine inhibits the reaction [Doxorubicin promotes the reaction [Iron binds to [FTL protein binds to FTMT protein]]] | affects binding|decreases reaction|increases reaction | 12644586
|
D004317 |
Doxorubicin |
Doxorubicin promotes the reaction [Iron binds to [FTL protein binds to FTMT protein]] | affects binding|increases reaction | 12644586
|
D004317 |
Doxorubicin |
Doxorubicin results in increased expression of FTL protein | increases expression | 16770644
|
D000431 |
Ethanol |
Ethanol results in increased expression of FTL mRNA | increases expression | 15963989
|
D005492 |
Folic Acid |
Folic Acid affects the expression of FTL mRNA | affects expression | 17868486
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide results in increased degradation of FTL protein | increases degradation | 16707465
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide results in increased expression of FTL mRNA | increases expression | 12414654
|
D006861 |
Hydrogen Peroxide |
MAP2K4 protein affects the reaction [Hydrogen Peroxide results in increased degradation of FTL protein] | affects reaction|increases degradation | 16707465
|
D007501 |
Iron |
2-pyridylcarboxaldehyde isonicotinoylhydrazone inhibits the reaction [Doxorubicin promotes the reaction [Iron binds to [FTL protein binds to FTMT protein]]] | affects binding|decreases reaction|increases reaction | 12644586
|
D007501 |
Iron |
2-pyridylcarboxaldehyde isonicotinoylhydrazone inhibits the reaction [Iron binds to [FTL protein binds to FTMT protein]] | affects binding|decreases reaction | 12644586
|
D007501 |
Iron |
Deferoxamine inhibits the reaction [Doxorubicin promotes the reaction [Iron binds to [FTL protein binds to FTMT protein]]] | affects binding|decreases reaction|increases reaction | 12644586
|
D007501 |
Iron |
Deferoxamine inhibits the reaction [Iron binds to [FTL protein binds to FTMT protein]] | affects binding|decreases reaction | 12644586
|
D007501 |
Iron |
Doxorubicin promotes the reaction [Iron binds to [FTL protein binds to FTMT protein]] | affects binding|increases reaction | 12644586
|
D007501 |
Iron |
FTL protein mutant form results in decreased uptake of Iron | decreases uptake | 16822677
|
D007501 |
Iron |
Iron binds to [FTL protein binds to FTMT protein] | affects binding | 12644586
|
D007501 |
Iron |
Paraquat promotes the reaction [Iron binds to [FTL protein binds to FTMT protein]] | affects binding|increases reaction | 12644586
|
D007501 |
Iron |
Razoxane inhibits the reaction [Iron binds to [FTL protein binds to FTMT protein]] | affects binding|decreases reaction | 12644586
|
D007501 |
Iron |
Vitamin K 3 promotes the reaction [Iron binds to [FTL protein binds to FTMT protein]] | affects binding|increases reaction | 12644586
|
D007501 |
Iron |
[CP gene mutant form results in increased abundance of Iron] which results in increased expression of FTL mRNA | increases abundance|increases expression | 16988052
|
D007501 |
Iron |
Copper promotes the reaction [[Iron co-treated with Diethylnitrosamine] results in increased expression of FTL mRNA] | affects cotreatment|increases expression|increases reaction | 20302851
|
D007501 |
Iron |
[Iron co-treated with Diethylnitrosamine] results in increased expression of FTL mRNA | affects cotreatment|increases expression | 20302851
|
C448299 |
iron protoporphyrin IX |
FTL protein binds to and affects the metabolism of iron protoporphyrin IX | affects binding|affects metabolic processing | 16781777
|
D017239 |
Paclitaxel |
FTL mRNA results in decreased susceptibility to Paclitaxel | decreases response to substance | 16322897
|
D010269 |
Paraquat |
Paraquat promotes the reaction [Iron binds to [FTL protein binds to FTMT protein]] | affects binding|increases reaction | 12644586
|
C023844 |
potassium nitrate |
potassium nitrate results in increased expression of FTL mRNA | increases expression | 15878651
|
D011929 |
Razoxane |
Razoxane inhibits the reaction [Iron binds to [FTL protein binds to FTMT protein]] | affects binding|decreases reaction | 12644586
|
C010327 |
salinomycin |
salinomycin results in decreased expression of FTL mRNA | decreases expression | 19682730
|
D012643 |
Selenium |
Selenium results in increased expression of FTL mRNA | increases expression | 19244175
|
C009277 |
sodium arsenate |
sodium arsenate results in increased expression of FTL mRNA | increases expression | 12727804
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of FTL mRNA | increases expression | 18465118
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of FTL mRNA | increases expression | 17218384
|
D024483 |
Vitamin K 3 |
Vitamin K 3 promotes the reaction [Iron binds to [FTL protein binds to FTMT protein]] | affects binding|increases reaction | 12644586
|
D024483 |
Vitamin K 3 |
Vitamin K 3 results in increased expression of FTL mRNA | increases expression | 12414654
|
D015054 |
Zymosan |
Zymosan analog results in increased expression of FTL mRNA | increases expression | 16239567
|
D015054 |
Zymosan |
Zymosan analog results in increased expression of FTL protein | increases expression | 16239567
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Ethanol |
7.49 | 18926900 17676605 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
7.49 | 11752688 15322242 14514962 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
9.49 | 18287403 |
MESH:D000138 |
Acidosis |
|
Ethanol |
9.49 | 11192467 |
MESH:D058186 |
Acute Kidney Injury |
|
Folic Acid |
4.07 | 16595132 16316344 17003819 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
4.30 | 11798837 19825857 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
4.30 | 17418594 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
6.48 | 6695378 10737359 |
MESH:D000236 |
Adenoma |
|
Folic Acid |
6.48 | 16963246 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
9.07 | 17620307 16434500 17162532 19061943 19052882 18056438 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.07 | 16835633 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
2,4-Dichlorophenoxyacetic Acid |
8.27 | 16132792 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Paraquat |
8.27 | 11874814 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.26 | 21441931 |
MESH:D020268 |
Alcohol-Induced Disorders, Nervous System |
|
Ethanol |
5.02 | 15451039 15451040 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.38 | 15955085 |
MESH:D019896 |
alpha 1-Antitrypsin Deficiency |
|
Iron |
5.36 | 16640825 |
MESH:D000544 |
Alzheimer Disease |
|
Copper |
6.53 | 16962711 16325427 16886094 17119284 16866297 16410023 |
MESH:D000544 |
Alzheimer Disease |
|
Folic Acid |
6.53 | 17116317 |
MESH:D000544 |
Alzheimer Disease |
|
Iron |
6.53 | 16640825 16563566 |
MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
Copper |
4.11 | 10694572 |
MESH:D000740 |
Anemia |
|
Iron |
13.53 | 16566752 16434484 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
13.53 | 11748828 |
MESH:D000740 |
Anemia |
|
Zymosan |
13.53 | 18664788 |
MESH:D018798 |
Anemia, Iron-Deficiency |
|
Copper |
9.62 | 16614410 |
MESH:D018798 |
Anemia, Iron-Deficiency |
|
Iron |
9.62 | 16569441 17147795 17162259 17375513 17163184 |
MESH:D000756 |
Anemia, Sideroblastic |
|
Iron |
4.55 | 16910769 |
MESH:D000853 |
Anophthalmos |
|
Ethanol |
4.53 | 15513904 |
MESH:D001008 |
Anxiety Disorders |
|
Ethanol |
3.77 | 11141031 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Iron |
4.12 | 16604332 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
7.14 | 16412693 |
MESH:D001169 |
Arthritis, Experimental |
|
Zymosan |
7.14 | 15142272 15188379 15944321 17659584 16872482 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.19 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.25 | 16456186 |
MESH:D001260 |
Ataxia Telangiectasia |
|
Iron |
5.15 | 15336622 |
MESH:D050197 |
Atherosclerosis |
|
Cadmium |
10.32 | 15687053 |
MESH:D050197 |
Atherosclerosis |
|
Cholesterol |
10.32 | 16632123 |
MESH:D050197 |
Atherosclerosis |
|
Iron |
10.32 | 16632123 16640825 |
MESH:D001321 |
Autistic Disorder |
|
Folic Acid |
2.66 | 21388746 |
MESH:D001321 |
Autistic Disorder |
|
Iron |
2.66 | 17352947 |
MESH:D001424 |
Bacterial Infections |
|
Iron |
4.90 | 16640825 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.12 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
13.81 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
13.81 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
13.81 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.49 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.58 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.40 | 14601052 |
MESH:D001859 |
Bone Neoplasms |
|
Paclitaxel |
4.29 | 15867366 |
MESH:D001932 |
Brain Neoplasms |
|
Carmustine |
13.40 | 16187019 |
MESH:D001932 |
Brain Neoplasms |
|
Copper |
13.40 | 17079463 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
13.40 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Copper |
5.52 | 17079463 15986119 |
MESH:D001943 |
Breast Neoplasms |
|
Deferoxamine |
5.52 | 15993339 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
5.52 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
5.52 | 15939500 15567936 16595493 18382427 18695136 15994142 15136595 17426702 16096432 16322301 15634643 18234424 18628466 15692762 19526202 16826403 16264153 15668708 16935488 15993339 16115903 11325840 17983394 17369602 |
MESH:D001943 |
Breast Neoplasms |
|
Folic Acid |
5.52 | 16777985 |
MESH:D001943 |
Breast Neoplasms |
|
Paclitaxel |
5.52 | 18323546 18223236 16244791 11325840 15136595 18234424 16273361 16115903 |
MESH:D001943 |
Breast Neoplasms |
|
salinomycin |
5.52 | 19682730 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
5.52 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
5.52 | 16166294 16443354 16873071 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.29 | 16813970 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.06 | 11589617 |
MESH:D002056 |
Burns |
|
Ethanol |
4.36 | 16374292 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.51 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.57 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.86 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
10.72 | 11135700 15073043 15553829 14691202 16217749 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
10.72 | 19208518 20727157 19394651 18665156 19701751 19418558 10672840 16935385 17761372 20214788 19052882 16569478 17978847 10737359 3581430 18971187 17138121 17428255 19539802 20935162 18210153 16830150 16328049 18691550 16502159 16807293 3084413 16681979 16288022 18785209 19335982 18056438 20084675 18978308 18506893 20007298 19919837 20101231 17055752 16698587 20514400 17162532 18788625 20524982 16878318 19107877 18393292 19383236 17173139 20512989 19519916 19822196 19171122 16540662 21159647 18494052 20432363 11831363 16779866 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
10.72 | 18059187 16023760 17876044 16234567 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Ethanol |
10.72 | 15763234 15289165 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Paclitaxel |
10.72 | 16313753 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
10.72 | 1917145 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.57 | 19014326 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
3.02 | 16201981 1485588 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
3.86 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
4.48 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
4.48 | 16051514 16096774 |
MESH:D006332 |
Cardiomegaly |
|
Copper |
10.60 | 17327471 |
MESH:D006332 |
Cardiomegaly |
|
Ethanol |
10.60 | 19332462 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
10.60 | 18850075 18670907 16120746 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
12.22 | 17329180 17382496 18627295 15792986 17351982 17928571 17308081 16455267 16269455 15476868 16364871 17924179 16651473 16612575 17131338 16242529 15505089 17007740 16278810 17974986 16731534 17519947 15811867 16109756 16952015 |
MESH:D009202 |
Cardiomyopathies |
|
Iron |
12.22 | 16640825 |
MESH:D009202 |
Cardiomyopathies |
|
Razoxane |
12.22 | 17519947 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
5.84 | 17334414 16243910 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Iron |
5.84 | 16604332 |
MESH:D002318 |
Cardiovascular Diseases |
|
Folic Acid |
7.09 | 16755160 |
MESH:D002318 |
Cardiovascular Diseases |
|
Hydrogen Peroxide |
7.09 | 16936243 |
MESH:D002386 |
Cataract |
|
Tretinoin |
2.92 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cadmium |
6.37 | 17332340 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
6.37 | 17174075 7505956 21159647 2727394 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.29 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
8.50 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
8.50 | 16835633 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.86 | 16461808 |
MESH:D002971 |
Cleft Lip |
|
Ethanol |
7.37 | 15513904 |
MESH:D002971 |
Cleft Lip |
|
Folic Acid |
7.37 | 21254359 |
MESH:D002972 |
Cleft Palate |
|
Ethanol |
13.09 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Folic Acid |
13.09 | 21254359 8946559 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
13.09 | 12621046 8697196 15340226 16354765 15668235 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
13.09 | 9407595 |
MESH:D003092 |
Colitis |
|
Selenium |
8.54 | 17936198 |
MESH:D003092 |
Colitis |
|
Tretinoin |
8.54 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
Iron |
2.84 | 16640825 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
4.61 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
4.61 | 18802399 18259882 |
MESH:D015179 |
Colorectal Neoplasms |
|
Folic Acid |
4.61 | 17245555 16963246 17116713 16985020 17087956 |
MESH:D015179 |
Colorectal Neoplasms |
|
Paclitaxel |
4.61 | 18802399 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.81 | 14669216 17141729 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
3.90 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
6.96 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Ethanol |
6.96 | 11198716 15451039 15451040 19302082 15513904 11873399 10194807 |
MESH:D019465 |
Craniofacial Abnormalities |
|
sodium arsenate |
6.96 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
6.96 | 15322242 20055451 10048152 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
6.96 | 16925845 9224671 17551590 9211117 10589399 9664655 8800419 9142499 9125849 14991402 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
3.82 | 15213294 |
MESH:D003866 |
Depressive Disorder |
marker/mechanism |
|
| 17063146 |
MESH:D003920 |
Diabetes Mellitus |
|
Iron |
4.21 | 16640825 16604332 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Iron |
3.27 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
9.66 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Folic Acid |
9.66 | 16886840 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Iron |
9.66 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
9.66 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
14.05 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
14.05 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Ethanol |
14.05 | 11566570 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
14.05 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
sodium arsenate |
14.05 | 18186108 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
14.05 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
7.39 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
7.39 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.23 | 11000095 12711302 |
MESH:D004487 |
Edema |
|
Zymosan |
6.23 | 7907874 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
10.94 | 15322242 16714409 18230668 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
10.94 | 18230668 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
11.51 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Folic Acid |
11.51 | 17301261 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
11.51 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.77 | 10568697 9294722 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
4.86 | 18037988 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.82 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
6.94 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Ethanol |
6.94 | 16704527 |
MESH:D004938 |
Esophageal Neoplasms |
|
Paclitaxel |
6.94 | 16481741 |
MESH:D017889 |
Exfoliation Syndrome |
|
Folic Acid |
5.20 | 16504073 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.11 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.11 | 16938888 9664655 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
16.70 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
16.70 | 20387270 21071580 |
MESH:D005234 |
Fatty Liver |
|
Ethanol |
16.70 | 19236843 18620774 16409862 |
MESH:D005234 |
Fatty Liver |
|
Iron |
16.70 | 16640825 |
MESH:D005235 |
Fatty Liver, Alcoholic |
|
Ethanol |
5.36 | 17920746 |
MESH:D005310 |
Fetal Alcohol Syndrome |
|
Ethanol |
5.00 | 16946407 10194807 15513904 15451040 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.17 | 11858732 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.29 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
7.66 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
7.66 | 17994277 |
MESH:D005621 |
Friedreich Ataxia |
|
Iron |
5.14 | 16640825 16604332 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
3.98 | 16904648 |
MESH:D005756 |
Gastritis |
|
Ethanol |
10.65 | 15046732 |
MESH:D005756 |
Gastritis |
|
Folic Acid |
10.65 | 17171786 |
MESH:D005901 |
Glaucoma |
|
Folic Acid |
4.81 | 16504073 |
MESH:D005909 |
Glioblastoma |
|
Carmustine |
10.91 | 16187019 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
10.91 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
10.91 | 17312396 |
MESH:D005911 |
Gliosis |
|
Paraquat |
4.86 | 11124998 |
MESH:D018149 |
Glucose Intolerance |
|
sodium arsenate |
4.81 | 19446573 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.29 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
7.19 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
7.19 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.86 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Folic Acid |
10.34 | 17286298 16524890 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
10.34 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
10.34 | 14991402 9664655 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
7.73 | 16879835 17888722 18006777 18674790 16244372 16330681 16495754 16244371 14766674 12587719 17875725 16144979 16707910 |
MESH:D006331 |
Heart Diseases |
|
Razoxane |
7.73 | 17875725 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
6.65 | 17481944 |
MESH:D006333 |
Heart Failure |
|
Selenium |
6.65 | 17162251 |
MESH:D006390 |
Hemangioendothelioma |
|
Razoxane |
6.11 | 15380572 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.64 | 15692506 |
MESH:D006432 |
Hemochromatosis |
|
Iron |
4.28 | 16574947 17236123 16640825 17053826 17255318 16604332 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.07 | 11000095 |
MESH:D006486 |
Hemosiderosis |
|
Iron |
4.91 | 16604332 |
MESH:D006505 |
Hepatitis |
|
Zymosan |
4.42 | 19110552 |
MESH:D006521 |
Hepatitis, Chronic |
|
Copper |
4.98 | 17338147 |
MESH:D006525 |
Hepatitis, Viral, Human |
|
Iron |
5.17 | 16640825 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Copper |
10.51 | 17182432 17276780 16607473 17109627 19888908 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Iron |
10.51 | 17182432 |
MESH:D006529 |
Hepatomegaly |
|
Iron |
7.79 | 16890145 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
7.79 | 12621046 16120746 15340226 |
MESH:D020271 |
Heredodegenerative Disorders, Nervous System |
marker/mechanism |
|
| 16825958 |
MESH:D015658 |
HIV Infections |
|
Iron |
3.52 | 16597321 |
MESH:D006679 |
HIV Seropositivity |
|
Folic Acid |
5.20 | 17209195 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.17 | 17606976 18501091 15147373 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.75 | 16959395 8697196 16354765 15340226 18606429 |
MESH:D006930 |
Hyperalgesia |
|
Ethanol |
7.24 | 18783367 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
7.24 | 16870215 |
MESH:D006937 |
Hypercholesterolemia |
|
Cholesterol |
4.71 | 16933029 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.28 | 16778211 |
OMIM:600886 |
HYPERFERRITINEMIA-CATARACT SYNDROME |
marker/mechanism |
|
| |
MESH:D020138 |
Hyperhomocysteinemia |
|
Folic Acid |
4.25 | 16395265 16865747 16433478 16397167 16755160 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.80 | 18670907 18850075 |
MESH:D007006 |
Hypogonadism |
|
Iron |
4.20 | 16640825 |
MESH:D007037 |
Hypothyroidism |
|
Iron |
4.79 | 16640825 |
MESH:D007248 |
Infertility, Male |
|
2,4-Dichlorophenoxyacetic Acid |
6.87 | 12948887 |
MESH:D007248 |
Infertility, Male |
|
Paraquat |
6.87 | 4850670 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
7.52 | 18785209 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
7.52 | 12200463 12878042 |
MESH:D007249 |
Inflammation |
|
Zymosan |
7.52 | 8014878 11289658 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
3.90 | 16624496 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.48 | 17994277 |
MESH:D007414 |
Intestinal Neoplasms |
|
caffeic acid phenethyl ester |
4.33 | 10783313 |
MESH:D019189 |
Iron Metabolism Disorders |
marker/mechanism |
|
| 16822677 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Iron |
4.76 | 17163184 |
MESH:D043183 |
Irritable Bowel Syndrome |
|
Zymosan |
5.54 | 17553498 |
MESH:D007569 |
Jaw Abnormalities |
|
Ethanol |
15.65 | 15513904 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
15.65 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
15.65 | 17551590 15992940 |
MESH:D007674 |
Kidney Diseases |
|
Cadmium |
9.39 | 16322080 16226777 16962696 |
MESH:D007674 |
Kidney Diseases |
|
caffeic acid phenethyl ester |
9.39 | 15369732 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
9.39 | 15699352 15369732 16775033 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Copper |
21.69 | 16518626 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
21.69 | 16707910 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Hydrogen Peroxide |
21.69 | 16518626 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
21.69 | 16518626 |
MESH:D007859 |
Learning Disorders |
|
Cholesterol |
14.70 | 17134702 |
MESH:D007859 |
Learning Disorders |
|
Copper |
14.70 | 17134702 |
MESH:D007859 |
Learning Disorders |
|
Ethanol |
14.70 | 15451040 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
5.85 | 15070760 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
5.85 | 17143497 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
4.86 | 16085563 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.53 | 12560223 17077332 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.01 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.21 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
8.60 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
8.60 | 16482212 16932348 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
5.95 | 16467208 20471514 17050201 19850784 16968895 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Deferoxamine |
5.95 | 20368581 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
5.95 | 19850784 16294345 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
11.73 | 12712474 17107899 11161223 19075265 15336539 16112521 9834237 11468182 17712046 19642359 15622746 16823087 16331271 19035177 16966277 17649720 16330433 15213294 15748426 19225113 12018890 16891316 17869043 17217047 12679006 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
caffeic acid phenethyl ester |
11.73 | 16766008 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
11.73 | 19075265 12679006 17361223 16766008 9834237 17107899 16891316 17339181 17712046 15748426 19035177 16331271 16788101 17506722 19642359 19029980 17294898 16140955 16823087 17301526 17649720 16935935 19225113 17217047 17368321 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.07 | 16882451 |
MESH:D020961 |
Lewy Body Disease |
|
Iron |
5.14 | 16563566 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Ethanol |
7.62 | 17676605 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
7.62 | 9224671 |
MESH:D008080 |
Liposarcoma |
|
Paclitaxel |
4.55 | 17353645 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
10.26 | 19638242 20032147 18407596 18665156 18522880 |
MESH:D008103 |
Liver Cirrhosis |
|
Ethanol |
10.26 | 15289165 |
MESH:D008103 |
Liver Cirrhosis |
|
Iron |
10.26 | 16640825 |
MESH:D008104 |
Liver Cirrhosis, Alcoholic |
|
Ethanol |
4.80 | 18295389 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
4.67 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Ethanol |
4.67 | 18166357 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
4.67 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
4.67 | 16248980 18397230 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
4.16 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
Folic Acid |
4.16 | 16877991 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Ethanol |
10.53 | 17347304 17207112 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Iron |
10.53 | 17207112 16737972 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
13.04 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Copper |
13.04 | 20302851 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
13.04 | 19427195 2862719 19996281 21071580 15885732 19551842 19255062 18977376 19256749 19642983 16942905 19294768 19833225 19090486 19850985 2422723 20501860 10737359 20434301 12112319 9163691 18644402 20118626 19254457 18978307 20137499 20583210 19638242 21167192 20452335 21047994 18754104 19073162 19812893 20101389 12771043 18648771 19426721 20405173 19690152 15175105 20492335 21278145 19499222 |
MESH:D008113 |
Liver Neoplasms |
|
Iron |
13.04 | 16640825 20302851 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
13.04 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
12.62 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
12.62 | 18164116 19009564 18253720 18775883 16842330 18079962 19004024 17942915 18282651 19539802 18308698 16267830 19126423 18544905 17174075 2563599 17854601 19519916 21159647 9362446 3124819 18093689 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
12.62 | 17085340 16842330 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
12.62 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.13 | 15213294 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
6.18 | 11798837 19825857 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
6.18 | 21163286 20970405 20512841 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
6.18 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Iron |
6.18 | 16640825 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
6.18 | 11884234 19555203 |
MESH:D008180 |
Lupus Erythematosus, Systemic |
|
Folic Acid |
3.25 | 17718048 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.25 | 16098063 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
2,4-Dichlorophenoxyacetic Acid |
13.43 | 16132792 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
13.43 | 17654614 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Paclitaxel |
13.43 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.28 | 15621674 |
MESH:D008268 |
Macular Degeneration |
|
Iron |
3.82 | 16640825 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
9.08 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
salinomycin |
9.08 | 19682730 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
9.08 | 15318939 |
MESH:D019767 |
Maxillofacial Abnormalities |
|
Folic Acid |
5.40 | 16832597 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.67 | 17453147 |
MESH:D008545 |
Melanoma |
|
Carmustine |
9.22 | 12393984 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
9.22 | 16827129 |
MESH:D008545 |
Melanoma |
|
Paclitaxel |
9.22 | 16342250 12025231 12040289 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
9.22 | 16752155 |
MESH:D008545 |
Melanoma |
|
Vitamin K 3 |
9.22 | 19082730 |
MESH:D008569 |
Memory Disorders |
|
Ethanol |
3.91 | 18411066 15451040 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.14 | 16940565 |
MESH:D007706 |
Menkes Kinky Hair Syndrome |
|
Copper |
5.58 | 17268249 17109627 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
5.89 | 17638057 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
5.89 | 15107826 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.23 | 15792986 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.49 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
6.81 | 19549372 19417148 14977855 11468182 15949261 |
MESH:D009101 |
Multiple Myeloma |
|
Paclitaxel |
6.81 | 14749477 |
MESH:D009102 |
Multiple Organ Failure |
|
Zymosan |
4.93 | 10479408 10890648 18160304 15213630 15834315 15259001 15241586 17724436 12130978 12879239 |
MESH:D020528 |
Multiple Sclerosis, Chronic Progressive |
|
Iron |
5.37 | 17086897 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
sodium arsenate |
4.59 | 18186108 |
MESH:D009181 |
Mycoses |
|
Iron |
5.17 | 16640825 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.37 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
6.83 | 16105982 16882451 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
6.83 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
2.83 | 19429709 15857846 |
MESH:D017202 |
Myocardial Ischemia |
|
Iron |
8.40 | 16604332 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
8.40 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Iron |
4.04 | 16604332 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
3.68 | 16624393 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
8.92 | 3581430 9029167 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
8.92 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Paclitaxel |
8.92 | 15867366 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
2.27 | 16946489 16594593 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Copper |
4.65 | 17308104 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.48 | 16636307 16899518 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
8.93 | 15640375 16889571 |
MESH:D009404 |
Nephrotic Syndrome |
|
Iron |
8.93 | 17178036 |
MESH:D009410 |
Nerve Degeneration |
|
Paraquat |
3.49 | 16893418 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
8.58 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
8.58 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
15.84 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
Folic Acid |
15.84 | 17438019 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenate |
15.84 | 19446573 18186108 10525206 11749123 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
15.84 | 9142499 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.11 | 15555623 |
OMIM:606159 |
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3 |
marker/mechanism |
|
| |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
7.89 | 20387270 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Iron |
7.89 | 17296847 16604332 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.82 | 20387270 |
MESH:D009503 |
Neutropenia |
|
Folic Acid |
4.23 | 16322990 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
Cholesterol |
5.42 | 20557099 9802331 |
MESH:D010003 |
Osteoarthritis |
|
Iron |
3.79 | 16640825 |
MESH:D010014 |
Osteolysis |
|
Paclitaxel |
4.68 | 15867366 |
MESH:D010024 |
Osteoporosis |
|
Iron |
3.68 | 16648989 16640825 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.88 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
7.41 | 19769630 16624393 12452020 |
MESH:D010051 |
Ovarian Neoplasms |
|
Paclitaxel |
7.41 | 11161223 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
7.41 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
2.67 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
11.44 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
11.44 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Ethanol |
11.44 | 12384795 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
11.44 | 15976015 |
MESH:D010212 |
Papilloma |
|
Hydrogen Peroxide |
8.72 | 12065085 |
MESH:D010212 |
Papilloma |
|
Iron |
8.72 | 12065085 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
3.89 | 19927285 |
MESH:D020447 |
Parasomnias |
|
Iron |
5.72 | 17352947 |
MESH:D010300 |
Parkinson Disease |
|
Iron |
5.33 | 16640825 16563566 |
MESH:D010300 |
Parkinson Disease |
|
Paraquat |
5.33 | 11181820 15824117 16510128 16140633 11124998 15451049 11445065 12911755 |
MESH:D010302 |
Parkinson Disease, Secondary |
|
Paraquat |
4.14 | 16190885 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.95 | 12520081 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Cadmium |
5.09 | 15687053 |
MESH:D010538 |
Peritonitis |
|
Zymosan |
4.59 | 19641140 14761945 18557954 18977430 17826846 17371808 19088179 15979727 15259001 18760300 11985352 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
4.86 | 17983394 |
MESH:D010900 |
Pituitary Diseases |
|
Iron |
5.37 | 16604332 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
4.59 | 15087411 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
4.86 | 17638057 |
MESH:D011014 |
Pneumonia |
|
Paraquat |
4.16 | 12504350 |
MESH:D011041 |
Poisoning |
|
Iron |
4.02 | 16604332 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Iron |
10.09 | 16640825 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
10.09 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
3.31 | 2563599 |
MESH:D011225 |
Pre-Eclampsia |
|
Iron |
4.20 | 16640825 |
MESH:D011248 |
Pregnancy Complications |
|
2,4-Dichlorophenoxyacetic Acid |
5.44 | 2087686 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
2.90 | 11399792 11222880 11118676 11896295 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
1.91 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cadmium |
1.91 | 17075824 |
MESH:D011471 |
Prostatic Neoplasms |
|
Copper |
1.91 | 17308104 17079463 |
MESH:D011471 |
Prostatic Neoplasms |
|
diallyl trisulfide |
1.91 | 17513609 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
1.91 | 16729912 15749863 18437689 15897917 16868541 16888761 |
MESH:D011471 |
Prostatic Neoplasms |
|
Paclitaxel |
1.91 | 17172428 17136230 16729912 16356831 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.33 | 16636307 |
MESH:D011528 |
Protozoan Infections |
|
Iron |
5.72 | 16640825 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.50 | 16723453 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Paraquat |
2.80 | 16324872 17997886 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
9.55 | 17922066 |
MESH:D051437 |
Renal Insufficiency |
|
Folic Acid |
9.55 | 15728788 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Paraquat |
3.64 | 11700416 |
MESH:D012135 |
Respiratory Sounds |
|
Paraquat |
3.77 | 11874814 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.56 | 18990726 |
MESH:D012148 |
Restless Legs Syndrome |
|
Iron |
4.33 | 16930377 |
MESH:D012162 |
Retinal Degeneration |
|
Paraquat |
3.65 | 16458197 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
3.83 | 16283617 16116481 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.73 | 16767912 18313854 15625365 17710206 17203757 15675481 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
9.34 | 16646077 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
9.34 | 16326096 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.49 | 17846226 |
MESH:D012559 |
Schizophrenia |
|
Copper |
4.10 | 16842975 |
MESH:D012559 |
Schizophrenia |
|
Folic Acid |
4.10 | 16641680 |
MESH:D012640 |
Seizures |
|
Ethanol |
2.98 | 9754883 |
MESH:D018805 |
Sepsis |
|
Zymosan |
4.41 | 11441115 |
MESH:D012871 |
Skin Diseases |
|
Folic Acid |
3.17 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
20.65 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Hydrogen Peroxide |
20.65 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
Iron |
20.65 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
20.65 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
20.65 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
20.65 | 16467112 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.28 | 16767912 15625365 17203757 |
MESH:D013118 |
Spinal Cord Diseases |
|
Folic Acid |
5.20 | 16361298 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
7.88 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
7.88 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Ethanol |
7.88 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Folic Acid |
7.88 | 17171786 |
MESH:D013274 |
Stomach Neoplasms |
|
Paclitaxel |
7.88 | 18506536 18396642 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
7.88 | 17261132 |
MESH:D013276 |
Stomach Ulcer |
|
Ethanol |
3.28 | 16755016 17918041 17189318 11906479 9562338 9211565 |
MESH:D020521 |
Stroke |
|
Folic Acid |
4.10 | 16517955 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Ethanol |
4.00 | 9754883 |
MESH:D013398 |
Sudden Infant Death |
|
Iron |
5.15 | 16640825 |
MESH:D024801 |
Tauopathies |
|
Paclitaxel |
4.52 | 16930453 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.60 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
15.29 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
15.29 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
15.29 | 16010429 17909728 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
15.29 | 17045167 16026305 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.53 | 16051514 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.67 | 15213294 |
MESH:D014376 |
Tuberculosis |
|
Iron |
7.57 | 16597321 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
7.57 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
4.86 | 20435036 12845720 11780464 12973940 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
4.86 | 17653716 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.42 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.31 | 16752155 |
MESH:D014605 |
Uveitis |
|
Zymosan |
5.10 | 11006244 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.29 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
3.93 | 17334414 17638931 17678736 16364871 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.78 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.95 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.72 | 16287080 |